153 related articles for article (PubMed ID: 35677856)
1. Kaposi's sarcoma associated with chronic myeloid leukemia and imatinib mesylate therapy.
D'Addona M; Pezzullo L; Giudice V; Serio B; Baldi C; Zeppa P; Selleri C
Clin Case Rep; 2022 Jun; 10(6):e05919. PubMed ID: 35677856
[TBL] [Abstract][Full Text] [Related]
2. Kaposi's sarcoma in a patient treated with imatinib mesylate for chronic myeloid leukemia.
Campione E; Diluvio L; Paternò EJ; Di Marcantonio D; Francesconi A; Terrinoni A; Orlandi A; Chimenti S
Clin Ther; 2009 Nov; 31(11):2565-9. PubMed ID: 20110001
[TBL] [Abstract][Full Text] [Related]
3. Molecularly targeted therapy for Kaposi's sarcoma in a kidney transplant patient: case report, "what worked and what did not".
Volkow P; Zinser JW; Correa-Rotter R
BMC Nephrol; 2007 Mar; 8():6. PubMed ID: 17386117
[TBL] [Abstract][Full Text] [Related]
4. Molecular studies in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors.
Sawyers CL
Semin Hematol; 2001 Jul; 38(3 Suppl 8):15-21. PubMed ID: 11526597
[TBL] [Abstract][Full Text] [Related]
5. Kaposi's sarcoma in an HIV-negative chronic lymphocytic leukemia patient without immunosuppressive therapy: A case report.
Vučinić D; Dekanić A; Zamolo G; Belušić-Gobić M; Belac-Lovasić I; Batinac T
SAGE Open Med Case Rep; 2018; 6():2050313X18799239. PubMed ID: 30210797
[TBL] [Abstract][Full Text] [Related]
6. PD166326, a novel tyrosine kinase inhibitor, has greater antileukemic activity than imatinib mesylate in a murine model of chronic myeloid leukemia.
Wolff NC; Veach DR; Tong WP; Bornmann WG; Clarkson B; Ilaria RL
Blood; 2005 May; 105(10):3995-4003. PubMed ID: 15657179
[TBL] [Abstract][Full Text] [Related]
7. A comprehensive review of imatinib mesylate (Gleevec) for dermatological diseases.
Scheinfeld N
J Drugs Dermatol; 2006 Feb; 5(2):117-22. PubMed ID: 16485879
[TBL] [Abstract][Full Text] [Related]
8. Kaposi's sarcoma-associated herpesvirus in Kaposi's sarcoma occurring in immunosuppressed renal transplant recipients.
Kedda MA; Margolius L; Kew MC; Swanepoel C; Pearson D
Clin Transplant; 1996 Oct; 10(5):429-31. PubMed ID: 8930456
[TBL] [Abstract][Full Text] [Related]
9. Disseminated Kaposi's sarcoma after heart transplantation: association with Kaposi's sarcoma-associated herpesvirus.
Fonseca R; Witzig TE; Olson LJ; Edwards BS; Khoor A; Walker RC
J Heart Lung Transplant; 1998 Jul; 17(7):732-6. PubMed ID: 9703241
[TBL] [Abstract][Full Text] [Related]
10. Glucose availability in hypoxia regulates the selection of chronic myeloid leukemia progenitor subsets with different resistance to imatinib-mesylate.
Giuntoli S; Tanturli M; Di Gesualdo F; Barbetti V; Rovida E; Dello Sbarba P
Haematologica; 2011 Feb; 96(2):204-12. PubMed ID: 21071498
[TBL] [Abstract][Full Text] [Related]
11. Immunological and inflammatory features of Kaposi's sarcoma and other Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8-associated neoplasias.
Riva G; Barozzi P; Torelli G; Luppi M
AIDS Rev; 2010; 12(1):40-51. PubMed ID: 20216909
[TBL] [Abstract][Full Text] [Related]
12. Kaposi's-sarcoma-associated herpesvirus is detected in peripheral blood mononuclear cells of HIV-infected homosexuals more often than in heterosexuals.
Rizzieri DA; Liu J; Miralles D; Traweek ST
Cancer J Sci Am; 1997; 3(3):153-6. PubMed ID: 9161780
[TBL] [Abstract][Full Text] [Related]
13. Mycosis fungoides and Kaposi's sarcoma association in an HIV-negative patient.
Bariani MC; Fleury LF; Ribeiro AM; Carneiro SS; Pereira TA
An Bras Dermatol; 2016; 91(5 suppl 1):108-110. PubMed ID: 28300912
[TBL] [Abstract][Full Text] [Related]
14. Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment.
Bhatia R; Holtz M; Niu N; Gray R; Snyder DS; Sawyers CL; Arber DA; Slovak ML; Forman SJ
Blood; 2003 Jun; 101(12):4701-7. PubMed ID: 12576334
[TBL] [Abstract][Full Text] [Related]
15. Kaposi's Sarcoma-Associated Herpesvirus Viral Interleukin-6 Signaling Upregulates Integrin β3 Levels and Is Dependent on STAT3.
Rivera-Soto R; Dissinger NJ; Damania B
J Virol; 2020 Feb; 94(5):. PubMed ID: 31801855
[TBL] [Abstract][Full Text] [Related]
16. Signal transduction targets in Kaposi's sarcoma.
Sullivan R; Dezube BJ; Koon HB
Curr Opin Oncol; 2006 Sep; 18(5):456-62. PubMed ID: 16894293
[TBL] [Abstract][Full Text] [Related]
17. Aberrant DNA methylation at HOXA4 and HOXA5 genes are associated with resistance to imatinib mesylate among chronic myeloid leukemia patients.
Elias MH; Azlan H; Sulong S; Baba AA; Ankathil R
Cancer Rep (Hoboken); 2018 Aug; 1(2):e1111. PubMed ID: 32721103
[TBL] [Abstract][Full Text] [Related]
18. Pathological Features of Kaposi's Sarcoma-Associated Herpesvirus Infection.
Katano H
Adv Exp Med Biol; 2018; 1045():357-376. PubMed ID: 29896675
[TBL] [Abstract][Full Text] [Related]
19. Human herpesvirus 8 (HHV-8) and the etiopathogenesis of Kaposi's sarcoma.
Leão JC; Caterino-De-Araújo A; Porter SR; Scully C
Rev Hosp Clin Fac Med Sao Paulo; 2002; 57(4):175-86. PubMed ID: 12244338
[TBL] [Abstract][Full Text] [Related]
20. Detection of herpesvirus-like sequences in Kaposi's sarcoma from heart transplant recipients.
Briz M; Alonso-Pulpon L; Crespo-Leiro MG; Exposito C; Almagro M; Busto MJ; Fernández MN
J Heart Lung Transplant; 1998 Mar; 17(3):288-93. PubMed ID: 9563605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
